1 |
Siri G, Alesaeidi S, Dizghandi SE, Alani B, Mosallaei M, Soosanabadi M. Analysis of SDC2 gene promoter methylation in whole blood for noninvasive early detection of colorectal cancer. J Cancer Res Ther 2022;18:S354-8. [PMID: 36510988 DOI: 10.4103/jcrt.jcrt_1072_22] [Reference Citation Analysis]
|
2 |
Li X, Wu Y, Tian T. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. Int J Mol Sci 2022;23. [PMID: 36430910 DOI: 10.3390/ijms232214436] [Reference Citation Analysis]
|
3 |
Yu W, He G, Zhang W, Ye Z, Zhong Z, Huang S. INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer. Front Genet 2022;13:933862. [DOI: 10.3389/fgene.2022.933862] [Reference Citation Analysis]
|
4 |
Li S, Chen J, Chen X, Yu J, Guo Y, Li M, Pu X. Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape. Front Pharmacol 2022;13:997664. [DOI: 10.3389/fphar.2022.997664] [Reference Citation Analysis]
|
5 |
Styk J, Buglyó G, Pös O, Csók Á, Soltész B, Lukasz P, Repiská V, Nagy B, Szemes T. Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer. Cancers 2022;14:3712. [DOI: 10.3390/cancers14153712] [Reference Citation Analysis]
|
6 |
Milner JJ, Chen Z, Grayson J, Shiao SPK. Obesity-Associated Differentially Methylated Regions in Colon Cancer. JPM 2022;12:660. [DOI: 10.3390/jpm12050660] [Reference Citation Analysis]
|